Picture of Elicera Therapeutics AB logo

ELIC Elicera Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Elicera Therapeutics Submits Clinical Trial Application

Jan 26 (Reuters) - Elicera Therapeutics AB  ELIC.ST :
    * ELICERA THERAPEUTICS SUBMITS CLINICAL TRIAL APPLICATION TO
EVALUATE ITS CAR T-CELL THERAPY IN B-CELL LYMPHOMA

Source text for Eikon:  ID:nWkrYtP2 
Further company coverage:  ELIC.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Elicera Therapeutics AB

See all news